The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered, Mov Disord, vol.21, issue.12, pp.2042-51, 2005. ,
Dementia with Lewy bodies: diagnosis and management: Third report of the DLB Consortium, Neurology, vol.65, pp.1863-72, 2005. ,
Dopamine, tremor and Parkinson's disease, Lancet, vol.340, issue.-, pp.125-126, 1992. ,
Missing pieces in the Parkinson's disease puzzle, Nat Med, vol.16, pp.653-61, 2010. ,
Divalent Metal Transporter 1 (DMT1) contributes to neurodegeneration in parkinsonian syndromes, Proc. Natl Acad. Sci. U.S.A, vol.105, pp.18578-18583, 2008. ,
-A deadly spread: cellular mechanisms of ?synuclein transfer, Cell Death Differ, vol.18, pp.1425-1433, 2011. ,
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol. and Histopathol, vol.25, pp.12-31, 1997. ,
-Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol, pp.382-397, 2009. ,
-Changes in cytokines and neurotrophins in Parkinson's disease, J Neural Transm, vol.60, pp.277-290, 2000. ,
-Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets, J. Immunol, vol.182, pp.4137-4149, 2009. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00608259
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism ,
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study, Brain, vol.133, pp.1755-1762, 2010. ,
Parkinsonism: onset, progression, and mortality, Neurology, vol.17, issue.5, pp.427-442, 1967. ,
DOI : 10.1212/WNL.17.5.427
-Motor complications in Parkinson's disease: ten year follow-up study, Mov Disord, vol.25, pp.2735-2739, 2010. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00025670
Cholinergic mesencephalic neurons are involved in gait and postural disorders in parkinsonian patients and monkeys, J. Clin. Invest, vol.120, pp.2745-54, 2010. ,
-Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson's disease and in progressive supranuclear palsy, Proc. Natl. Acad. Sci. U.S.A, vol.84, pp.5976-5980, 1987. ,
URL : https://hal.archives-ouvertes.fr/hal-00840181
Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease, Neuroreport, vol.16, pp.1877-1881, 2005. ,
Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?, J Neural Transm, vol.118, pp.1469-1475, 2011. ,